YIL 781

CAS No. 875258-85-8

YIL 781( —— )

Catalog No. M33951 CAS No. 875258-85-8

YIL 781 is a selective ghrelin receptor antagonist (GHS-R1a) (Ki = 17 nM), showing a weak affinity for kinesin receptors (K = 6 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 119 In Stock
5MG 92 In Stock
10MG 147 In Stock
25MG 312 In Stock
50MG 458 In Stock
100MG 641 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    YIL 781
  • Note
    Research use only, not for human use.
  • Brief Description
    YIL 781 is a selective ghrelin receptor antagonist (GHS-R1a) (Ki = 17 nM), showing a weak affinity for kinesin receptors (K = 6 μM).
  • Description
    YIL781 is a potent and orally active ghrelin receptor (GHSR) antagonist. YIL781 produces a greater improvement in glucose homeostasis in rats. YIL781 inhibits the calcium response induced by ghrelin with pIC50 values of 7.90 and 8.27, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    GHSR
  • Recptor
    GHSR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    875258-85-8
  • Formula Weight
    409.5
  • Molecular Formula
    C24H28FN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (244.20 mM; Ultrasonic )
  • SMILES
    O=C1C=2C(N=C(C)N1C[C@@H]3CN(C(C)C)CCC3)=CC=C(OC4=CC=C(F)C=C4)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. William P Esler, et al. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss Endocrinology. 2007 Nov;148(11):5175-85.?
molnova catalog
related products
  • ONC212

    ONC212 a fluorinated-ONC201 analogue is a selective agonist of GPR132.

  • JMV 2959

    JMV 2959 is a growth hormone secretagogue receptor type 1a (GHS-R1a) antagonist with an IC50 of 32 nM.

  • TAPI-1

    TAPI-1, an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors.